Hetero Labs Limited Emtricitabine Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Emtricitabine Export Records India — #6 Exporter, 67 Shipments, $3.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Emtricitabine

India Pharmaceutical Trade Intelligence

$119.4M141 Suppliers117 CountriesHS 30049099

ExportsIndia → SOUTH AFRICA26.2%India → UNITED STATES13.1%

ImportsUNITED STATES → India$942.1K CANADA → India$171.0K

#1 Supplier: MYLAN LABORATORIES

Hetero Labs Limited — Emtricitabine Exporter #6 | $3.4M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Emtricitabine Exporter Profile

Indian Pharmaceutical Exporter · #6 for Emtricitabine · $3.4M export value · DGFT Verified

Hetero Labs Limited is the #6 Indian exporter of Emtricitabine with $3.4M in export value and 67 verified shipments. Hetero Labs Limited holds a 2.8% market share in Emtricitabine exports across 26 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Emtricitabine Export Profile: Buyers & Destinations

Hetero Labs Limited Emtricitabine export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Emtricitabine?

Country	Value	Shipments	Share
MALAYSIA	$327.6K	9	15.9%
UNITED KINGDOM	$250.0K	5	12.2%
GERMANY	$209.5K	5	10.2%
UNITED STATES OF AMERICA	$150.0K	3	7.3%

Who Are the Top Buyers of Emtricitabine from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	BELARUS	$680.3K	19
M S TO THE ORDER OFCAMBER PHARMACEUTICAL CO LIMITED	THAILAND	$95.0K	2
M S TO THE ORDER OF MEDISPEC M SDN	MALAYSIA	$90.4K	3
ALLIANCE FOR PUBLIC HEALTH,	UKRAINE	$80.6K	3
TO THE ODRER OF	NAMBIA	$79.0K	3
M S TO THE ORDER OF ALLOGA UK	UNITED KINGDOM	$50.0K	1
XXN AXXRICXX HEXXTH XXGANXXATIXX	ARGENTINA	$50.0K	1
XXN AXXRICXX HEXXTH XXGANXXATIXX SUXXLY XXNAGXXENT	ARGENTINA	$50.0K	1
CHARITABLE ORGANIZATION	POLAND	$50.0K	1
UNOPS MYANMAR	MYANMAR	$50.0K	1

Hetero Labs Limited supplies Emtricitabine to 22 buyers globally. The largest buyer is TO THE ORDER OF (BELARUS), followed by M S TO THE ORDER OFCAMBER PHARMACEUTICAL CO LIMITED (THAILAND) and M S TO THE ORDER OF MEDISPEC M SDN (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Emtricitabine Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
TENOFOVIR DISOPROXIL FUMARATE + EMTRICITABINE	$258.6K	7
EFAVIRENZ EMTRICITABINE AND TENOFOVIR	$161.5K	7
TENOFOVIR DISOPROXIL FUMARATE MG+EMTRICITABINE MG QTY: 25,000 PACKS PACK OF 30'S	$150.0K	3
EMTRICITABINE AND TENOFOVIRTENOFOVIR DIS+EMTRICITAB TE-300MG+EM-200MG TABLET 30SNOS	$80.6K	3
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALATABLET 30S (QTY: 9000 CON)	$79.0K	3
TENOF EM TENOFOVIR DISOPROXIL FUMARATEEMTRICITABINE TABS	$74.3K	2
TENOFOVIR DISOPROXIL FUMARATE 245 EMTRICITABINE 200 TABS 11000 X 30 330000	$50.0K	1
TENOFOVIR DISOPROXIL FUMARATE 245 EMTRICITABINE 200 TABS 8244 X 30 247320	$50.0K	1
TENOFOVIR DISOPROXIL FUMARATE 245 EMTRICITABINE 200 TABS 3712 X 30 111360	$50.0K	1
EMTRITEN TENOFOVIR DISOPROXIL FUMARATE 300 MG EMTRICITABINE 200 MG 67250 X 30S PACKS 2017500 NOS	$50.0K	1

Hetero Labs Limited exports 42 distinct Emtricitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TENOFOVIR DISOPROXIL FUMARATE + EMTRICITABINE with 7 shipments worth $258.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Hetero Labs Limited Compare to Nearest Emtricitabine Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	AUROBINDO PHARMA LTD	$5.9M	118	9	$50.0K
7	MACLEODS PHARMACEUTICALS LIMITED	$4.2M	107	19	$38.8K
6	HETERO LABS LIMITED ★	$3.4M	67	26	$50.0K
8	AUROBINDO PHARMA LIMITED	$2.9M	58	6	$50.0K
4	LUPIN LIMITED	$2.1M	43	4	$50.0K

Hetero Labs Limited ranks #6 among 141 Indian Emtricitabine exporters. Average shipment value of $50.0K compared to the market average of $363.2K. The closest competitors by value are AUROBINDO PHARMA LTD and MACLEODS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Emtricitabine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	524	23.9%
SAHAR AIR	469	21.4%
Bombay Air	166	7.6%
DELHI AIR	153	7.0%
DELHI AIR CARGO ACC (INDEL4)	141	6.4%
NHAVA SHEVA SEA (INNSA1)	60	2.7%
Bombay Air Cargo	55	2.5%
HYDERABAD ACC (INHYD4)	54	2.5%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Emtricitabine Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Emtricitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 67 individual customs records matching Hetero Labs Limited exporting Emtricitabine, covering 42 formulations to 26 countries via 22 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 117+ countries, 493+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Emtricitabine

Emtricitabine

Hetero Labs Limited — Emtricitabine Exporter Profile

Hetero Labs Limited — Emtricitabine Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Emtricitabine?

Who Are the Top Buyers of Emtricitabine from Hetero Labs Limited?

What Is India's Total Emtricitabine Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Emtricitabine Exports?

How Does Hetero Labs Limited Compare to Other Indian Emtricitabine Exporters?

What Emtricitabine Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Emtricitabine to Key Markets

United Kingdom — MHRA

Germany — BfArM/EMA

How Does Hetero Labs Limited Compare to Nearest Emtricitabine Exporters?

Which Indian Ports Ship Emtricitabine Exports?

What Other Antiviral & HIV Medications Products Does Hetero Labs Limited Export?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Emtricitabine Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Emtricitabine Export Data from Hetero Labs Limited

Emtricitabine Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source